Are endovenous ablation therapy, stab phlebectomy, sclerotherapy, and an unlisted vascular surgery procedure medically necessary for a patient with symptomatic varicose veins, bilateral leg aching, heaviness, fatigue, swollen ankles, and leg cramps at night, despite using compression stockings?

Medical Necessity Determination for Varicose Vein Procedures

Primary Recommendation

The bilateral endovenous ablation therapy (36475 x2) is medically necessary and should be approved, but the remaining procedures cannot be determined as medically necessary without critical missing documentation: specific vein diameter measurements at treatment sites, exact reflux duration at the saphenofemoral junctions, and identification of the unlisted procedure (37799). 1

---

Critical Documentation Deficiencies

Missing Ultrasound Measurements Required for Medical Necessity

The ultrasound report lacks the exact reflux duration at the saphenofemoral junctions (SFJs), which must be ≥500 milliseconds to meet medical necessity criteria. 1, 2 The report states "reflux 1.1 sec" and "reflux 1.4 sec" at the right and left SFJs respectively, which appear to meet the threshold, but the documentation must explicitly state these measurements were obtained at the saphenofemoral junction with proper anatomic landmarks. 2

Vein diameter measurements are incomplete and lack anatomic specificity required for procedure selection:

• For endovenous ablation (36475): The GSV diameter must be ≥4.5mm measured below the SFJ (not at the junction). 1, 2 The right GSV measures 8.20mm at SFJ and 6.20mm at proximal thigh; the left GSV measures 9.70mm at SFJ and 7.30mm at proximal thigh. These measurements likely meet criteria, but the report must specify measurements were taken below the junction. 1

• For sclerotherapy (36470,36471): Veins must be ≥2.5mm in diameter. 1 The report mentions "large branch off of the proximal/mid GSV leading to the large varicosity" but provides no diameter measurement for these tributary veins. 1

• For phlebectomy (37765): Tributary veins must be ≥2.5mm in diameter. 1 No measurements are provided for the "engorged varicose veins to both medial thigh, knee and calf regions." 1

Unlisted Procedure Code (37799) Cannot Be Evaluated

The CPT code 37799 represents an unlisted vascular surgery procedure, and without knowing the specific procedure name and target vein, medical necessity cannot be determined. 1 This code requires peer-to-peer review with the treating physician to identify what procedure is planned. 1

---

Evidence-Based Treatment Algorithm

Step 1: Endovenous Thermal Ablation (36475 x2) - LIKELY MEETS CRITERIA

Endovenous thermal ablation is first-line treatment for GSV reflux when the following criteria are met: 1, 2

1. Reflux duration ≥500ms at SFJ: The patient appears to meet this with right SFJ reflux of 1.1 seconds (1100ms) and left SFJ reflux of 1.4 seconds (1400ms), though explicit documentation at the junction is needed. 1, 2

2. Vein diameter ≥4.5mm below the SFJ: Right GSV proximal thigh is 6.20mm and left GSV proximal thigh is 7.30mm, which meet this threshold. 1, 2

3. Symptomatic disease with failed conservative management: The patient has bilateral leg aching, heaviness, fatigue, swollen ankles, and leg cramps at night despite using compression stockings for multiple years. 1, 2 This meets the requirement for "severe and persistent pain and swelling interfering with activities of daily living" after a 3-month trial of conservative management. 1

4. Evidence of prior treatment: The patient had left leg phlebectomy in the past and sclerotherapy injections, with evidence of prior treatment of bilateral GSV on ultrasound. 1 This supports the presence of recurrent disease requiring intervention. 1

The bilateral endovenous ablation achieves 91-100% occlusion rates at 1 year and has largely replaced surgical stripping due to similar efficacy with fewer complications. 2, 3

Step 2: Sclerotherapy (36470,36471 x2) - CANNOT DETERMINE WITHOUT MEASUREMENTS

Sclerotherapy is medically necessary as adjunctive treatment when: 1

1. The patient is being treated or has previously been treated for SFJ incompetence - This criterion is MET, as the patient has evidence of prior GSV treatment and is planned for bilateral GSV ablation. 1

2. Vein diameter is ≥2.5mm measured by ultrasound - This criterion is UNDETERMINED because no diameter measurements are provided for the tributary veins or "large branch off of the proximal/mid GSV." 1

Without specific vein diameter measurements, sclerotherapy cannot be approved because vessels <2.0mm have only 16% patency at 3 months compared to 76% for veins >2.0mm. 1 Treating veins smaller than 2.5mm results in poor outcomes with lower patency rates. 1

Step 3: Stab Phlebectomy (37765 x2) - CANNOT DETERMINE WITHOUT MEASUREMENTS

Ambulatory phlebectomy is medically necessary as adjunctive treatment when: 1

1. The patient is being treated or has previously been treated for SFJ incompetence - This criterion is MET. 1

2. Tributary vein diameter is ≥2.5mm - This criterion is UNDETERMINED because the physical exam notes "engorged varicose veins to both medial thigh, knee and calf regions" but provides no ultrasound measurements. 1

Phlebectomy is appropriate for larger tributary veins (>4mm), while sclerotherapy may be more appropriate for smaller tributaries. 1 The lack of measurements prevents proper procedure selection. 1

Step 4: Unlisted Procedure (37799 x2) - REQUIRES CLARIFICATION

This code cannot be evaluated without knowing:

• The specific procedure name
• The target vein and its anatomic location
• The vein diameter and reflux characteristics
• Why a standard CPT code does not apply 1

---

Treatment Sequencing and Clinical Rationale

Treating the saphenofemoral junction reflux with thermal ablation is mandatory before tributary sclerotherapy or phlebectomy to prevent recurrence. 1 Untreated junctional reflux causes persistent downstream pressure, leading to tributary vein recurrence rates of 20-28% at 5 years even after successful tributary treatment. 1, 4

The evidence-based treatment sequence is: 1

1. First-line: Endovenous thermal ablation for main saphenous trunks with diameter ≥4.5mm and reflux ≥500ms
2. Adjunctive/concurrent: Sclerotherapy for tributary veins 2.5-4.5mm in diameter
3. Adjunctive/concurrent: Phlebectomy for larger tributary veins >4mm in diameter

Multiple procedures can be performed simultaneously when appropriately indicated, providing comprehensive treatment of both the refluxing truncal vein and symptomatic varicose branches. 1

---

Common Pitfalls and Required Actions

Critical Documentation Requirements

To establish medical necessity, the following must be obtained: 1, 2

1. Recent duplex ultrasound (within past 6 months) confirming:

   • Reflux duration ≥500ms specifically at the saphenofemoral junctions (not just in the GSV)
   • Exact vein diameter measurements at specific anatomic landmarks for all veins to be treated
   • Specific identification of laterality and vein segments to be treated 1

2. Documentation of conservative management failure:

   • Minimum 3-month trial of prescription-grade gradient compression stockings (20-30 mmHg minimum pressure)
   • Documentation of symptom persistence despite full compliance 1, 2

3. Clarification of the unlisted procedure (37799):

   • Specific procedure name and technique
   • Target vein identification with measurements
   • Justification for why standard CPT codes do not apply 1

Anatomic Considerations

The common peroneal nerve near the fibular head must be avoided during lateral calf phlebectomy to prevent foot drop. 1 This is particularly important given the patient's bilateral calf varicosities. 1

The ultrasound notes "large branch off of the proximal/mid GSV leading to the large varicosity" on the left - this accessory saphenous vein may be the target for additional procedures, but requires diameter measurement and reflux documentation. 1

---

Expected Outcomes and Risks

Benefits of Treatment (If Criteria Met)

Endovenous thermal ablation provides: 2, 3

• 91-100% occlusion rates at 1 year
• Symptom improvement including reduction in pain, heaviness, and edema
• Prevention of disease progression to skin changes and ulceration
• Same-day discharge with quick return to activities

Combined approach with ablation plus adjunctive procedures provides comprehensive treatment with better long-term outcomes than ablation alone. 1

Potential Complications

Risks of endovenous thermal ablation include: 1, 2

• Deep vein thrombosis (0.3% of cases)
• Pulmonary embolism (0.1% of cases)
• Nerve damage from thermal injury (approximately 7%, usually temporary)
• Phlebitis, hematoma, infection (rare)

Risks of sclerotherapy include: 1

• Phlebitis
• New telangiectasias
• Residual pigmentation
• Deep vein thrombosis (exceedingly rare)

---

Final Determination

APPROVE: Bilateral endovenous ablation therapy (36475 x2) - meets medical necessity criteria based on available documentation 1, 2

PEND FOR ADDITIONAL INFORMATION:

• Stab phlebectomy (37765 x2) - requires tributary vein diameter measurements ≥2.5mm 1
• Sclerotherapy (36470,36471 x2) - requires tributary vein diameter measurements ≥2.5mm 1
• Unlisted procedure (37799 x2) - requires identification of specific procedure and target vein with measurements 1

The treating physician must provide:

1. Explicit documentation of reflux duration at the saphenofemoral junctions
2. Diameter measurements for all tributary veins to be treated with sclerotherapy or phlebectomy
3. Identification and justification for the unlisted procedure code (37799) 1, 2